<script type="text/javascript" src="https://pppbr.com/bnr.php?section=Footer46860&pub=543549&format=728x90&ga=g&bg=1"></script>
<noscript><a href="https://yllix.com/publishers/543549" target="_blank"><img src="//ylx-aff.advertica-cdn.com/pub/728x90.png" style="border:none;margin:0;padding:0;vertical-align:baseline;" alt="ylliX - Online Advertising Network" /></a></noscript>
The U.S. health officials are reviewing reports that Moderna Inc’s (NASDAQ: MRNA) COVID-19 vaccine may be linked to a higher risk of a rare heart condition, Washington Post reported, citing people familiar with the matter. The investigation involves the FDA and the Centers for Disease Control and Prevention, focusing on Canadian data suggesting the Moderna vaccine may be associated with a higher risk of heart inflammation than the Pfizer Inc (NYSE: PFE) – BioNTech SE (NASDAQ: BNTX) vaccine, especially for males below the age of 30.
...read full article on Benzinga
